HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever ‘Fully Committed’ To Israel Business, Ben & Jerry’s Uproar Notwithstanding

Executive Summary

Ben & Jerry’s values may not square with parent Unilever when it comes to business in disputed West Bank territory, where the former’s ice cream will no longer be sold. CEO Alan Jope says only that Unilever remains committed to its business in Israel, where it has invested more than ILS 1bn over the last decade.

You may also be interested in...



Unilever Compass Points To LGBTQI+, Animals, Earth

Unilever aims to be “the leader in sustainable business globally” under its sustainability Compass unveiled in May 2020. One year later, the firm announces a series of measures benefiting people, animals and planet.

EU Business Round-Up: Unilever Steps Up Sustainability, BioGaia Makes Finnish Move, Monat Heads To Spain

The latest EU business news: Unilever unveils planned switch to sustainable toothpaste tubes; BioGaia takes back distribution in key market Finland; and Monat continues its European expansion into Spain and Lithuania.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151590

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel